These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 19765913
21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
22. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Fritz P, Kraus HJ, Blaschke T, Mühlnickel W, Strauch K, Engel-Riedel W, Chemaissani A, Stoelben E. Lung Cancer; 2008 May 15; 60(2):193-9. PubMed ID: 18045732 [Abstract] [Full Text] [Related]
23. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, Wloch J, Ye H, Kestin LL. J Clin Oncol; 2010 Feb 20; 28(6):928-35. PubMed ID: 20065181 [Abstract] [Full Text] [Related]
24. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. Radiother Oncol; 2009 Dec 20; 93(3):402-7. PubMed ID: 19559492 [Abstract] [Full Text] [Related]
25. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Brown WT, Wu X, Fayad F, Fowler JF, García S, Monterroso MI, de la Zerda A, Schwade JG. Clin Oncol (R Coll Radiol); 2009 Oct 20; 21(8):623-31. PubMed ID: 19682875 [Abstract] [Full Text] [Related]
28. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH, Woo SY, Cui NJ, Butler EB. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):682-7. PubMed ID: 14967420 [Abstract] [Full Text] [Related]
29. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, Molls M. Acta Oncol; 2006 Mar 01; 45(7):796-801. PubMed ID: 16982542 [Abstract] [Full Text] [Related]
31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569 [Abstract] [Full Text] [Related]
32. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY. Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):117-25. PubMed ID: 16765528 [Abstract] [Full Text] [Related]
33. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, Ikenaga S, Araki T, Uematsu M. Lung Cancer; 2004 Jul 01; 45(1):45-55. PubMed ID: 15196734 [Abstract] [Full Text] [Related]
34. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Dvorak P, Georg D, Bogner J, Kroupa B, Dieckmann K, Pötter R. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1572-81. PubMed ID: 15817364 [Abstract] [Full Text] [Related]
35. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R, Molls M, Nieder C, Geinitz H. Radiother Oncol; 2011 Nov 01; 101(2):245-9. PubMed ID: 21724287 [Abstract] [Full Text] [Related]
36. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer. Djärv E, Nyman J, Baumann P, Ekberg L, Høyer M, Lax I, Lewensohn R, Levin N, Lund JA, Morhed E, Ericsson SR, Traberg A, Wittgren L, Johansson KA. Acta Oncol; 2006 Nov 01; 45(7):973-7. PubMed ID: 16982566 [Abstract] [Full Text] [Related]
37. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer. Fonteyne V, De Gersem W, De Neve W, Jacobs F, Lumen N, Vandecasteele K, Villeirs G, De Meerleer G. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1013-20. PubMed ID: 19386427 [Abstract] [Full Text] [Related]
38. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE. Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1283-6. PubMed ID: 19028267 [Abstract] [Full Text] [Related]